SWOT Analysis for Bluebird bio Inc

High Normalized Momentum Score
Relative Outperformance versus Industry over 1 Week
Significant (over 30%) distance from 52 week high
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over Half Year (6 Months)
Relative Outperformance versus Industry over 1 Year
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Month
Increasing profits every quarter for the past 2 quarters
Stock with Low PE (PE < = 10)
Volume Shockers
Highest Recovery from 52 Week Low

Promoter decreasing their shareholding
Companies with growing costs YoY for long term projects
Stocks with Quarter Change % less than Industry
Negative profit growth, promoters decreasing shareholding QoQ
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of shareholder funds - ROE declining in the last 2 years
Highest fall from 52 Week High
Top Losers
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Book Value Per Share deteriorating for last 2 years
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter